Source comparison
MOTS-C Nasal vs Subcutaneous: Administration Method Comparison
Bioavailability 70–85% systemic absorption 15–25% systemic absorption Subcutaneous delivers 3–4× higher plasma concentrations at equivalent nominal doses Peak Plasma Time 45–90 minutes post-injection 20–40 minutes post-administration Nasal achieves faster peak
This comparison does not assign a generated winner or score.
- Bioavailability
- 70–85% systemic absorption
- 15–25% systemic absorption
- Subcutaneous delivers 3–4× higher plasma concentrations at equivalent nominal doses
- Peak Plasma Time
- 45–90 minutes post-injection
- 20–40 minutes post-administration
- Nasal achieves faster peak but at much lower absolute levels
- Dose Precision
- High. Syringe-measured to 0.01mL
- Moderate. Fixed actuation volume, variable mucosal absorption
- Subcutaneous offers tighter control over delivered dose
- Administration Skill
- Requires injection technique, sterile handling
- No injection skill required, minimal learning curve
- Nasal spray eliminates injection barriers entirely
- Compliance Rate
- 85–90% in studies requiring daily dosing
- 95–98% in studies requiring daily dosing
- Subjects consistently prefer nasal delivery over injections
- Cost Per Equivalent Systemic Dose
- Lower. No absorption loss compensation
- Higher. Requires 3–4× nominal dose to match subcutaneous levels
- Subcutaneous is more cost-efficient per milligram delivered
- Storage Requirements
- Refrigeration at 2–8°C post-reconstitution
- Room temperature stable for 60–90 days once opened
- Nasal spray offers logistical simplicity for travel or field work
- Injection Site Reactions
- 5–10% incidence, resolves within 48 hours
- None. No injection site
- Nasal eliminates local tissue reactions but may cause nasal irritation in <2%